MedTrace Logo

Assessment of Fitness After Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients

NCT01334593 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2013-01-03

No results posted yet for this study

Summary

Neoadjuvant chemoradiotherapy (NACRT) prior to surgery for lower gastrointestinal (colon and rectal) cancer is associated with improved survival, but also adversely affects physical fitness, potentially rendering patients unfit for major surgery or increasing the risk of adverse outcome (death and serious complications) after major surgery. The investigators aim to obtain pilot data showing that neoadjuvant chemoradiotherapy (NACRT)reduces objectively measured exercise capacity (fitness).

Conditions

Sponsors & Collaborators

  • Michelle Mossa

    lead OTHER_GOV

Principal Investigators

  • Malcolm A West · Aintree University Hospitals NHS Foundation Trust, Liverpool, UK

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01334593 on ClinicalTrials.gov